N-myc Promotes Survival and Induces S-phase Entry of Postmitotic Sympathetic Neurons
Overview
Affiliations
In most postmitotic neurons, expression or activation of proteins that stimulate cell cycle progression or DNA replication results in apoptosis. One potential exception to this generalization is neuroblastoma (NB), a tumor derived from the sympathoadrenal lineage. NBs often express high levels of N-myc, a proto-oncogene that can potently activate key components of the cell cycle machinery. Here, we show that in postmitotic sympathetic neurons, N-myc can induce S-phase entry while protecting neurons from death caused by aberrant cell cycle reentry. Specifically, these experiments demonstrate that expression of N-myc at levels similar to those in NBs caused sympathetic neurons to reenter S-phase, as monitored by 5-bromo-2-deoxyuridine incorporation and expression of cell cycle regulatory proteins, and rescued them from apoptosis induced by withdrawal of their obligate survival factor, nerve growth factor. The N-myc-induced cell cycle entry, but not enhanced survival, was inhibited by coexpression of a constitutively hypophosphorylated form of the retinoblastoma tumor suppressor protein, suggesting that these two effects of N-myc are mediated by separate pathways. In contrast, N-myc did not cause S-phase entry in postmitotic cortical neurons. Thus, N-myc both selectively causes sympathetic neurons to reenter the cell cycle and protects them from apoptosis, potentially contributing to their transformation to NBs.
Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma.
Chen C, Lan M Biology (Basel). 2022; 11(10).
PMID: 36290282 PMC: 9598261. DOI: 10.3390/biology11101376.
Dain Md Opo F, Alkarim S, Alrefaei G, Molla M, Alsubhi N, Alzahrani F Curr Issues Mol Biol. 2022; 44(10):4838-4858.
PMID: 36286044 PMC: 9600652. DOI: 10.3390/cimb44100329.
LncRNA EPIC1 downregulation mediates hydrogen peroxide-induced neuronal cell injury.
Sun J, Zheng J, Li Y, Yan M, Li P, Ma L Aging (Albany NY). 2019; 11(23):11463-11473.
PMID: 31812951 PMC: 6932932. DOI: 10.18632/aging.102545.
Neuroblastoma-A Neural Crest Derived Embryonal Malignancy.
Johnsen J, Dyberg C, Wickstrom M Front Mol Neurosci. 2019; 12:9.
PMID: 30760980 PMC: 6361784. DOI: 10.3389/fnmol.2019.00009.
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.
Kholodenko I, Kalinovsky D, Doronin I, Deyev S, Kholodenko R J Immunol Res. 2018; 2018:7394268.
PMID: 30116755 PMC: 6079467. DOI: 10.1155/2018/7394268.